While the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per
dose, herd immunity might be two years away due to implementation
challenges, the brokerage said, adding the experience in large scale
adult vaccination programmes is thin.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-may-get-covid-19-vaccine-by-early-2021-says-bernstein-research/articleshow/77804704.cms
No comments:
Post a Comment